H19 and Igf2 are closely linked, reciprocally imprinted genes which lie on distal chromosome 7 in the mouse. Data suggests that common elements are used for expression and imprinting of both genes, and simple models have been proposed based on the presence of a single set of enhancers located downstream of H19. In this study we have investigated the H19 expression pattern from a 130 kb YAC transgene, which imprints H19 appropriately at ectopic loci. However, we show that while enhancers for expression in many cell types are present on the YAC, those for expression in mesodermal components of the heart, kidney, lung and thymus are located at a greater distance. Based on the available evidence, we conclude that regulation of H19 is complex, requiring contribution from at least three different sets of cell-type speci®c enhancers. Thus, the mechanism of reciprocal imprinting of H19 and Igf2 utilises different regulatory elements in different cell types during mouse development. q
Results and discussion
It has been shown that enhancers which lie less than 10 kb downstream of the mouse H19 gene control expression of both H19 and Igf2 in a subset of cell types (Leighton et al., 1995; Brenton et al., 1999) . We recently demonstrated that a YAC transgene (YZ) spanning from 90 kb upstream to 35 kb downstream of H19 has an additional, functionally distinct enhancer containing region which directs expression in skeletal muscle for both genes (Ainscough et al., 1997) . This transgene was also able to appropriately imprint both H19 and Igf2 when integrated as a single copy locus, at ectopic sites.
In this study we have examined the expression pattern of H19 from this YAC transgene during development, in mice lacking the endogenous H19 transcription unit. A single copy transgene, YZ8, and a ten copy transgene, YZ15, (Ainscough et al., 1997) were crossed onto the homozygous H19D 3 null background (Ripoche et al., 1997) . At day 14 of embryogenesis we found that transgenic H19 activity was restricted in a cell-type speci®c manner when compared to the endogenous pattern of expression, in tissues of both endodermal and mesodermal origin (Fig. 1) . The pattern was the same for both transgenic lines analysed. Strong expression was seen in the liver and in skeletal muscle cells, including those of the tongue (Fig. 2B,D) . However, no expression was seen in the other types of muscle cell (cardiac and smooth) which also normally express H19. Cell type speci®c expression was also seen in the epithelial layers of the gut, lung and kidney, but was absent from other cell types in these tissues (Fig. 2B ). This strongly suggested that at least one or more distinct set(s) of enhancer elements is located beyond the ends of the YAC transgene, and therefore at a great distance from the H19 gene.
To further characterise the restricted H19 expression pattern at a different stage of development we looked in neonates by RT-PCR analysis on isolated tissues. For this we utilised an Msp1 polymorphism present in exon 1 of H19 (Fig. 3A) , (Ainscough et al., 1997) . The single and ten copy transgenes (YZ8 and YZ15) were crossed onto the BALB/c background, which contains a second Msp1 site in the region ampli®ed. Transgenic progeny from female transmission were selected for analysis. Consistent with the pro®le seen by in situ analysis at day 14 of embryogenesis, expression was seen from both the maternal endogenous allele and that from the YAC in liver, skeletal muscle (including tongue), and gut ( Fig. 3B ). However, only the endogenous allele was predominantly detected in the kidney, heart and thymus. Analysis of the ten copy transgene con®rmed that transgenic H19 expression in the heart was barely detectable (Fig. 3C ).
Since consistent results were seen in the two transgenic , similar to that seen from the endogenous maternal allele (A). However expression in the lung and gut, including the stomach, was restricted to the epithelial cell layers (B). Similar epithelial restricted expression was also noted in the kidney (not shown). No activity was seen in smooth muscle or mesenchyme derived cells throughout the body (B). No expression was detected in the cardiac muscle cells of the heart (B). Skeletal muscle cells throughout the body showed a high level of H19 expression from the transgene, including those in the body of the tongue (D). However, little expression was seen in the connective tissue of the tongue, when compared to the widespread expression seen from the endogenous maternal allele (C). Gu, gut; He, heart; Li, liver; Lu, lung; Mu, muscle; To, tongue.
lines the cell type speci®c H19 expression pro®le from the YAC was not a result of position effects at the site of integration. The pattern seen was therefore an accurate representation of enhancer activity from the YAC transgene. We conclude that the elements required to direct complete expression of the mouse H19 gene are located in at least three distinct regions spread over more than 130 kb. One set is located just downstream of H19 and is mostly endoderm speci®c. The second set is present on the YAC and is skeletal muscle speci®c, while the additional set(s) are external to the YAC and are mostly mesoderm speci®c. The H19-Igf2 region is part of a much larger domain, containing additional imprinted genes that are all located upstream of Igf2 (see Ainscough et al., 1998) . The nearest known gene downstream of H19 is L23mrp which is located approximately 35 kb away and is not imprinted (Zubair et al., 1997) . L23mrp is ubiquitously expressed and does not appear to utilise the known enhancers downstream of H19. Interestingly the TNNT3 gene, which lies downstream of the L23MRP/L23mrp gene in human and rat, is speci®cally expressed in fast skeletal muscle ®bres, from both parental alleles (Yuan et al., 1996) . It was suggested that H19 and TNNT3 may share, but not compete for, skeletal muscle speci®c enhancer(s). Our data would indicate that such enhancers must be located upstream of the L23mrp gene.
If the remaining H19 mesoderm speci®c enhancers (those not present on the YAC) are located downstream of H19 they must lie beyond L23mrp, since the YAC transgene used in the present study extends as far as this gene. Alternatively, the enhancers may lie upstream of Igf2, within the chromatin environment which contains additional imprinted genes. This is perhaps more likely, especially as the YAC used in our studies only extends 1±2 kb upstream of Igf2.
These ®ndings demonstrate the complexities involved in controlling expression of imprinted genes on mouse distal chromosome 7, which has important implications for the underlying mechanism(s) of H19 imprinting. This notion is further supported by the identi®cation of tissue speci®c RT-PCR analysis of H19 exon 1 in transgenic neonates containing a maternally inherited endogenous BALB/c allele, and a maternally inherited single copy, YZ8, transgene. MspI digested reaction products were hybridised with the 321 bp probe shown in A. One representative sample is shown for each tissue analysed. Expression was detected from the endogenous BALB/c allele in all tissues analysed. However, H19 expression from the transgene was only detected at signi®cant levels in the liver (Li), skeletal muscles (Mu), including tongue (To), and to a lesser extent, the gut (Gu). Little, or no, transgenic expression was detected in the kidney (Ki), heart (He) or thymus (Th). (C) Analysis of the ten copy transgene, YZ15, con®rmed that no expression could be detected from the transgene in the heart (He), whereas transgene expression in the liver (Li), skeletal muscle (Mu) and tongue (To) showed copy number dependency, being expressed at higher levels than the endogenous allele.
H19 and/or Igf2 silencer elements in the region (Brenton et al., 1999, and manuscripts in preparation) . A functionally distinct element has also been de®ned which is involved in initiating the H19 imprint (Thorvaldsen et al., 1998) . Available evidence also indicates a possible role for boundary element(s) to block enhancer interaction with H19 on the paternally inherited chromosome, and Igf2 on the maternally inherited chromosome (Schmidt et al., 1999) .
Thus, numerous elements, scattered over a wide domain, are involved in regulating the H19 and Igf2 genes throughout development. The precise way in which this array of elements is coordinated to direct the reciprocal imprinting of these two genes has yet to be determined, but is clearly more complex than current models suggest.
Materials and methods

In situ hybridization
In situ hybridization analysis was performed as described (John et al., 1999) , using in vitro transcribed, DIG labelled probe from a 2 kb H19 cDNA clone.
RNA and expression analysis
RT-PCR was performed on total RNA prepared from day 5 neonatal tissues using Trizol (Gibco BRL). Primers 624, 5 H -TGGGGGAAGATGGGAGAGCT-3 H and 625, 5 H ATCC-CATGGTCTCTGCCACT3
H were used to amplify the polymorphic region of mouse H19 exon 1 using an annealing temperature of 608C for 30 cycles. MspI digested products were separated on 2% agarose, transferred to Hybond N1 and hybridised with a 32 P-dCTP labelled 321 bp internal probe using the random primers DNA labelling system (Gibco BRL).
Mice used in this study
F 1 (C57BL/6 £ CBA) and BALB/c mice were used throughout these experiments. The YAC clone was derived from C3H mice, and transgenic lines were as described (Ainscough et al., 1997) . H19 null mice used for in situ analysis were as described (Ripoche et al., 1997) .
